COPD exacerbator phenotype: time for reassessment?

Affiliations

¹ Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The State University of New York at Buffalo, Buffalo, NY 14215, USA.
² Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The State University of New York at Buffalo, Buffalo, NY 14215, USA. Electronic address: mador@buffalo.edu.

Comment

Zahi Nachef et al. Lancet Respir Med. 2017 Aug.

. 2017 Aug;5(8):600-601.

doi: 10.1016/S2213-2600(17)30236-9. Epub 2017 Jun 28.

¹ Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The State University of New York at Buffalo, Buffalo, NY 14215, USA.
² Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The State University of New York at Buffalo, Buffalo, NY 14215, USA. Electronic address: mador@buffalo.edu.

No abstract available

Comment on

Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Han MK, Quibrera PM, Carretta EE, Barr RG, Bleecker ER, Bowler RP, Cooper CB, Comellas A, Couper DJ, Curtis JL, Criner G, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Krishnan JA, Martinez CH, Pirozzi CB, O'Neal WK, Rennard S, Tashkin DP, Wedzicha JA, Woodruff P, Paine R 3rd, Martinez FJ; SPIROMICS investigators. Han MK, et al. Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28. Lancet Respir Med. 2017. PMID: 28668356 Free PMC article.